27 mars 2015
Clinical Trials in 2014
Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca This study is currently recruiting participants. (see Contacts and Locations ) Verified October 2014 by Ocular Technologies SARL Sponsor:...